Follow
Hye Sang Park
Hye Sang Park
Medical Doctor
Verified email at santpau.cat
Title
Cited by
Cited by
Year
Assessment of EULAR/ACR-2019, SLICC-2012 and ACR-1997 classification criteria in SLE with longstanding disease
B Magallares, D Lobo-Prat, I Castellví, P Moya, I Gich, ...
Journal of clinical medicine 10 (11), 2377, 2021
172021
Minimal disease activity (MDA) in patients with recent-onset psoriatic arthritis: predictive model based on machine learning
R Queiro, D Seoane-Mato, A Laiz, EG Agirregoikoa, C Montilla, HS Park, ...
Arthritis Research & Therapy 24 (1), 153, 2022
142022
Efficacy of belimumab in Primary Sjögren's syndrome: A systematic review
N Álvarez-Rivas, H Sang-Park, PD Del Campo, M Fernández-Castro, ...
Reumatología Clínica (English Edition) 17 (3), 170-174, 2021
132021
Spanish registry of recent-onset psoriatic arthritis (REAPSER study): aims and methodology
R Queiro, A Laiz, D Seoane-Mato, EG Agirregoikoa, C Montilla, HS Park, ...
Reumatología Clínica (English Edition) 15 (5), 252-257, 2019
112019
SER recommendations on the use of biological drugs in primary Sjögren's syndrome
JLA Sánchez, MF Castro, PD del Campo Fontecha, H Corominas, ...
Reumatología Clínica (English Edition) 15 (6), 315-326, 2019
92019
Severe disease in patients with recent-onset psoriatic arthritis. prediction model based on machine learning
R Queiro, D Seoane-Mato, A Laiz, E Galindez Agirregoikoa, C Montilla, ...
Frontiers in Medicine 9, 891863, 2022
82022
Valve abnormalities, risk factors for heart valve disease and valve replacement surgery in spondyloarthritis. A systematic review of the literature
HS Park, A Laiz, J Sanchez-Vega, P Diaz del Campo, MA Martín-Martínez, ...
Frontiers in Cardiovascular Medicine 8, 719523, 2021
82021
Patient-related factors influencing the effectiveness and safety of Janus Kinase inhibitors in rheumatoid arthritis: a real-world study
C Martinez-Molina, I Gich, C Diaz-Torné, HS Park, A Feliu, S Vidal, ...
Scientific Reports 14 (1), 172, 2024
32024
Effectiveness and safety of anakinra in gouty arthritis: A case series and review of the literature
S Jeria-Navarro, A Gomez-Gomez, HS Park, E Calvo-Aranda, ...
Frontiers in Medicine 9, 1089993, 2023
32023
Role of IL6R Genetic Variants in Predicting Response to Tocilizumab in Patients with Rheumatoid Arthritis
L Sainz, P Riera, P Moya, S Bernal, J Casademont, C Díaz-Torné, ...
Pharmaceutics 14 (9), 1942, 2022
32022
Confounders contributing to explain the association between sex and disease impact in patients with recent-onset psoriatic arthritis
R Queiro, D Seoane-Mato, A Laiz, EG Agirregoikoa, C Montilla, HS Park, ...
Clin. Exp. Rheumatol, 2022
32022
Recomendaciones SER sobre la utilización de fármacos biológicos en el síndrome de Sjögren primario
JLA Sánchez, MF Castro, PD del Campo Fontecha, H Corominas, ...
Reumatología Clínica 15 (6), 315-326, 2019
22019
AB0788 Differences in the phenotypic expression of recent onset psoriatic arthritis among men and women: baseline data from the reapser study
R Queiro, AL Alonso, HS Park, CM Morales, EG Agirregoikoa, JJB Baute, ...
Annals of the Rheumatic Diseases 76 (Suppl 2), 1333-1333, 2017
22017
Moderate-High Disease Activity in Patients with Recent-Onset Psoriatic Arthritis—Multivariable Prediction Model Based on Machine Learning
R Queiro, D Seoane-Mato, A Laiz, E Galindez Agirregoikoa, C Montilla, ...
Journal of Clinical Medicine 12 (3), 931, 2023
12023
Clinical Value of IL6R Gene Variants as Predictive Biomarkers for Toxicity to Tocilizumab in Patients with Rheumatoid Arthritis
L Sainz, P Riera, P Moya, S Bernal, J Casademont, C Díaz-Torné, ...
Journal of Personalized Medicine 13 (1), 61, 2022
12022
Characteristics associated with the perception of high-impact disease (PsAID≥ 4) in patients with recent-onset psoriatic arthritis. Machine learning-based model
R Queiro, D Seoane-Mato, A Laiz, EG Agirregoikoa, C Montilla, HS Park, ...
Seminars in arthritis and rheumatism 57, 152097, 2022
12022
AB0643 IL-1 BLOCKAGE WITH ANAKINRA IN GOUT PATIENTS. SCOPING REVIEW OF THE PUBLISHED LITERATUR.
S Jeria Navarro, H Park, MA Pou, E Calvo-Aranda, C Diaz-Torne
Annals of the Rheumatic Diseases 80 (Suppl 1), 1354-1355, 2021
12021
AB0594 EFFECTIVENESS OF RITUXIMAB IN CSDMARDS-RESISTANT ACTIVE MIXED CONNECTIVE TISSUE DISEASE
L Montolio-Chiva, J Narváez, JJ Alegre-Sancho, JL Pons, AVO Vera, ...
Annals of the Rheumatic Diseases 79 (Suppl 1), 1593-1594, 2020
12020
THU0603 Suitability of PET-CT in refractory polymyalgia rheumatica
ME Corica, P Moya, A Fernandez, B Magallares, I Gich, AMM Arciniegas, ...
Annals of the Rheumatic Diseases 78 (Suppl 2), 593-595, 2019
12019
THU0562 Evolution of serum calprotectin in patients with juvenile idiopathic arthritis in clinical practice
BM López, L Martínez-Martínez, MC Hernandez-Lafuente, E Moltó, ...
Annals of the Rheumatic Diseases 77 (Suppl 2), 482-483, 2018
12018
The system can't perform the operation now. Try again later.
Articles 1–20